Neurotech partners with University of Sydney to advance Rett syndrome program

Neurotech International has entered a research collaboration with the University of Sydney to advance its proprietary ...
FiercePharma

Neurotech's vision loss cell therapy implant hits primary goals in phase 3 trials

A pair of phase 3 trials of Neurotech Pharmaceuticals’ encapsulated cell therapy implant have met their primary endpoints, positioning the biotech to talk to the FDA about bringing the treatment for a ...
Fast Company

With neurotech, control over our minds is less absolute than we think

Socrates, the ancient Greek philosopher, never wrote things down. He warned that writing undermines memory—that it is nothing but a reminder of some previous thought. Compared to people who discuss ...
FiercePharma

Neurotech nabs FDA approval to treat rare eye disorder with cell therapy implant Encelto

With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech Pharmaceuticals is on the verge of making its commercial debut. The FDA last week ...
Business Wire

Motif Neurotech Raises $18.75 Million in Series A Financing to Advance Implantable Device for Treatment-Resistant Depression

- Funding to advance development of miniature implantable stimulator to unlock minimally invasive therapies for treatment-resistant neuropsychiatric disorders HOUSTON--(BUSINESS WIRE)--Motif Neurotech ...
Forbes

How AI Is Advancing NeuroTech

Neurotechnologies are based on the principles of the human nervous system and modeled on the human brain. NeuroTech can help researchers understand brain function and disfunction, and can help doctors ...
The Business Journals

Rice startup Motif Neurotech lands $18.7M Series A round to fund depression-treating device

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Motif Neurotech, one of the ...